You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PMBCL

Showing 1 - 25 of 40
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Mediastinal Large B-cell Lymphoma (PMBCL), Primary Mediastinal Large B Cell Lymphoma, Primary Mediastinal Large B-Cell

Not yet recruiting
  • Primary Mediastinal Large B-cell Lymphoma (PMBCL)
  • +5 more
  • Boston, Massachusetts
  • +1 more
Jun 28, 2023

CNS Involvement in Primary Mediastinal Large B-Cell Lymphoma

Active, not recruiting
  • Primary Mediastinal Large B-cell Lymphoma (PMBCL)
  • DISEASE
  • (no location specified)
May 4, 2023

Primary Mediastinal Large B-cell Lymphoma With CNS Involvement

Recruiting
  • Primary Mediastinal Large B-cell Lymphoma (PMBCL)
    • Milan, Italy
      Ospedale San Raffaele
    Aug 29, 2023

    Bio-CAR-T BS Study

    Recruiting
    • Diffuse Large B Cell Lymphoma (DLBCL)
    • +2 more
      • Brescia, Italy
        ASST Spedali Civili di Brescia
      May 5, 2022

      Large B-cell Lymphoma, DLBCL, Not Otherwise Specified, Primary Mediastinal Large B-cell Lymphoma (PMBCL) Trial (Epcoritamab)

      Available
      • Large B-cell Lymphoma
      • +4 more
      • Epcoritamab
      • (no location specified)
      Feb 16, 2023

      Non-hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma Trial in Boston (CD79b-19 CAR T cells,

      Not yet recruiting
      • Non-hodgkin Lymphoma
      • +9 more
      • CD79b-19 CAR T cells
      • +2 more
      • Boston, Massachusetts
        Massachusetts General Hospital
      Sep 6, 2023

      Diffuse Large-Cell Lymphoma, Primary Mediastinal Large B-Cell Lymphoma (PMBCL), Transformed Follicular Lymphoma (TFL) Trial in

      Recruiting
      • Diffuse Large-Cell Lymphoma
      • +3 more
      • Pneumococcal conjugate vaccine (PCV13)
      • CD19 targeted CAR T Cell Therapy
      • Tampa, Florida
        Moffitt Cancer Center
      May 31, 2022

      Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma Trial in United States (P-CD19CD20-ALLO1, Rimiducid)

      Not yet recruiting
      • Diffuse Large B Cell Lymphoma
      • +5 more
      • La Jolla, California
      • +7 more
      Aug 25, 2023

      CAR T Cell Therapy Related Cardiovascular Outcomes

      Recruiting
      • Cardiovascular Diseases
      • +7 more
        • London, United Kingdom
          University College London Hospitals
        Nov 18, 2021

        Non Hodgkin Lymphoma (NHL), Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukemia (CLL) Trial in Milwaukee (8/12-Day

        Recruiting
        • Non Hodgkin Lymphoma (NHL)
        • +6 more
        • 8/12-Day Production of Car-T Cells
        • +2 more
        • Milwaukee, Wisconsin
          Medical College of Wisconsin and Froedtert Hospital
        Jul 1, 2022

        Refractory Aggressive B-cell Lymphomas, Refractory B-Cell Non-Hodgkin Lymphoma, Aggressive B-cell NHL Trial in Boston

        Not yet recruiting
        • Refractory Aggressive B-cell Lymphomas
        • +12 more
        • Boston, Massachusetts
        • +1 more
        Oct 13, 2022

        Anaplastic Large Cell Lymphoma, Peripheral T Cell Lymphoma, Extranodal NK/T-cell Lymphoma Trial in Duarte, Nashville, Houston

        Active, not recruiting
        • Anaplastic Large Cell Lymphoma
        • +4 more
        • Duarte, California
        • +3 more
        Jul 21, 2022

        CD20+, B-cell Lymphomas, Mantle Cell Lymphoma, Non-Mantle Cell Low Grade B Cell Lymphomas (SLL/CLL) Trial in Baltimore

        Completed
        Has Results
        • CD20+, B-cell Lymphomas
        • +5 more
        • Baltimore, Maryland
          Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
        Oct 4, 2021

        Primary Mediastinal Large B Cell Lymphoma, EBV-Positive DLBCL, Nos Trial in Shanghai (Zanubrutinib, Tislelizumab)

        Recruiting
        • Primary Mediastinal Large B Cell Lymphoma
        • EBV-Positive DLBCL, Nos
        • Shanghai, Shanghai, China
          Ruijin Hospital
        Mar 29, 2021

        Relapsed Large B-cell Lymphoma, Refractory Large B-cell Lymphoma, Diffuse Large B-cell Lymphoma (DLBCL) Trial in Seoul (CRC01,

        Recruiting
        • Relapsed Large B-cell Lymphoma
        • +5 more
        • CRC01
        • +2 more
        • Seoul, Korea, Republic of
          Samsung Medical Center
        Apr 29, 2021

        Classical Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma (DLBCL), Primary Mediastinal Large B-cell Lymphoma (PMBCL) Trial in

        Not yet recruiting
        • Classical Hodgkin Lymphoma
        • +2 more
        • Lifestyles Implemented-Survivorship Care Plan (LS-SCP)
        • Ancona, Italy
        • +39 more
        Jun 28, 2023

        Primary Mediastinal Large B-Cell Lymphoma (PMBCL) Trial in China (LP002)

        Not yet recruiting
        • Primary Mediastinal Large B-Cell Lymphoma (PMBCL)
        • Beijing, Beijing, China
        • +6 more
        Oct 19, 2020

        Hodgkin's Lymphoma, Primary Mediastinal Large B-cell Lymphoma (PMBCL) Trial in Worldwide (Pembrolizumab)

        Active, not recruiting
        • Hodgkin's Lymphoma
        • Primary Mediastinal Large B-cell Lymphoma (PMBCL)
        • Pembrolizumab
        • Torrance, California
        • +26 more
        Oct 20, 2022

        Primary Mediastinal (Thymic) Large B-Cell Lymphoma Trial in Worldwide (drug, biological, radiation)

        Recruiting
        • Primary Mediastinal (Thymic) Large B-Cell Lymphoma
        • Birmingham, Alabama
        • +187 more
        Jan 31, 2023

        Lymphomas Non-Hodgkin's B-Cell, Diffuse Large B-cell Lymphoma (DLBCL), Primary Mediastinal B-cell Lymphoma (PMBCL) Trial in

        Recruiting
        • Lymphomas Non-Hodgkin's B-Cell
        • +5 more
        • WZTL002-1 (1928T2z CAR-T cells)
        • Cyclophosphamide and Fludarabine lymphodepleting chemotherapy
        • Wellington, New Zealand
          Wellington Hospital, Capital & Coast District Health Board
        Feb 18, 2020

        B Cell Malignancies Trial in Beijing, Shenzhen, Haikou (Universal CD19-specific CAR gene-engineered T cells)

        Recruiting
        • B Cell Malignancies
        • Universal CD19-specific CAR gene-engineered T cells
        • Beijing, Beijing, China
        • +2 more
        Aug 8, 2023

        Hematologic Malignancy Trial in Bologna

        Recruiting
        • Hematologic Malignancy
          • Bologna, Italy
            Programma Dipartimentale Terapie Cellulari Avanzate
          Apr 17, 2023

          Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma Trial in United States (IMPT-314)

          Not yet recruiting
          • Relapsed Non-Hodgkin Lymphoma
          • Refractory Non-Hodgkin Lymphoma
          • Los Angeles, California
          • +3 more
          Apr 12, 2023

          Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular Trial in United States

          Recruiting
          • Lymphoma, Non-Hodgkin
          • +3 more
            • Hot Springs, Arkansas
            • +12 more
            Apr 14, 2022

            B-cell Non-Hodgkin Lymphoma (B-NHL), B-cell Acute Lymphoblastic Lymphoma (B-ALL) Trial (PIT565)

            Not yet recruiting
            • B-cell Non-Hodgkin Lymphoma (B-NHL)
            • B-cell Acute Lymphoblastic Lymphoma (B-ALL)
            • PIT565
            • (no location specified)
            Jun 13, 2022